Fiduciary Family Office LLC Buys Shares of 29,348 Monogram Orthopaedics, Inc. (NASDAQ:MGRM)

Fiduciary Family Office LLC purchased a new position in shares of Monogram Orthopaedics, Inc. (NASDAQ:MGRM) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 29,348 shares of the company’s stock, valued at approximately $70,000. Fiduciary Family Office LLC owned approximately 0.09% of Monogram Orthopaedics as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also modified their holdings of the company. Geode Capital Management LLC lifted its stake in shares of Monogram Orthopaedics by 1,267.4% in the 3rd quarter. Geode Capital Management LLC now owns 210,144 shares of the company’s stock valued at $557,000 after acquiring an additional 194,776 shares during the last quarter. State Street Corp acquired a new position in Monogram Orthopaedics in the 3rd quarter worth about $62,000. Finally, Barclays PLC bought a new position in Monogram Orthopaedics in the third quarter valued at about $29,000. 0.45% of the stock is currently owned by institutional investors.

Monogram Orthopaedics Stock Up 6.3 %

Shares of NASDAQ:MGRM opened at $2.85 on Thursday. The firm has a market cap of $97.78 million, a P/E ratio of -6.06 and a beta of 1.51. Monogram Orthopaedics, Inc. has a 12-month low of $1.53 and a 12-month high of $4.90. The business has a fifty day simple moving average of $2.40 and a 200 day simple moving average of $2.49.

Analysts Set New Price Targets

Several analysts have recently weighed in on the company. Roth Capital upgraded Monogram Orthopaedics to a “strong-buy” rating in a report on Monday, December 9th. Roth Mkm initiated coverage on shares of Monogram Orthopaedics in a report on Monday, December 9th. They set a “buy” rating and a $4.00 target price on the stock.

Monogram Orthopaedics Profile

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.